Mark Sidhom

Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial

Andrew Kneebone, Carol Fraser‐Browne, Gillian Duchesne et al. · The Lancet Oncology · 2020 · 349 citations · Full text

Surgical Oncology, Urology, Radiation Therapy +10

Post-prostatectomy radiation therapy: Consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary Group

Mark Sidhom, Andrew Kneebone, Margot Lehman et al. · Radiotherapy and Oncology · 2008 · 187 citations

Urology, Surgical Oncology, Genitourinary Cancer +7

A <scp>P</scp> hase <scp>III</scp> trial to investigate the timing of radiotherapy for prostate cancer with high‐risk features: background and rationale of the Radiotherapy – Adjuvant Versus Early Salvage ( <scp>RAVES</scp> ) trial

Maria Pearse, Carol Fraser‐Browne, Ian D. Davis et al. · British Journal of Urology · 2014 · 112 citations · Full text

Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial

Shankar Siva, Mathias Bressel, Mark Sidhom et al. · The Lancet Oncology · 2024 · 93 citations

Urology, Surgical Oncology, Radiation Therapy +7

Do Multidisciplinary Meetings Follow Guideline-Based Care?

Shalini Vinod, Mark Sidhom, Geoff P. Delaney · Journal of Oncology Practice · 2010 · 70 citations · Full text